5fnf
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Dynamic Undocking and the Quasi-Bound State as tools for Drug Design== | ==Dynamic Undocking and the Quasi-Bound State as tools for Drug Design== | ||
| - | <StructureSection load='5fnf' size='340' side='right' caption='[[5fnf]], [[Resolution|resolution]] 2.10Å' scene=''> | + | <StructureSection load='5fnf' size='340' side='right'caption='[[5fnf]], [[Resolution|resolution]] 2.10Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5fnf]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FNF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FNF FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5fnf]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FNF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FNF FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TQL:4-[(E)-N-OXIDANYL-C-PYRIDIN-3-YL-CARBONIMIDOYL]BENZENE-1,3-DIOL'>TQL</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TQL:4-[(E)-N-OXIDANYL-C-PYRIDIN-3-YL-CARBONIMIDOYL]BENZENE-1,3-DIOL'>TQL</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fnc|5fnc]], [[5fnd|5fnd]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fnc|5fnc]], [[5fnd|5fnd]]</td></tr> | ||
| Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5fnf" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5fnf" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Heat Shock Protein structures|Heat Shock Protein structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Baker, L M]] | [[Category: Baker, L M]] | ||
[[Category: Barril, X]] | [[Category: Barril, X]] | ||
Revision as of 07:12, 6 November 2019
Dynamic Undocking and the Quasi-Bound State as tools for Drug Design
| |||||||||||
Categories: Human | Large Structures | Baker, L M | Barril, X | Davis, B | Hubbard, R | Luque, F J | Matassova, N | Murray, J | Roughley, S | Ruiz-Carmona, S | Schmidtke, P | Chaperone | Drug design | Hsp90 | Oncology
